News

Raven Industries, Inc. (the Company; NASDAQ:RAVN) announced today the release of its Hawkeye^® 2 Nozzle Control System. Available to order today, the system offers users unparalleled spray

Raven Industries, Inc. (the Company; NASDAQ:RAVN) announced today that its board of directors has indefinitely suspended the Company’s regular quarterly cash dividend on its common stock.

By

Raven Industries, Inc. (the Company; NASDAQ:RAVN) today reported financial results for the second quarter that ended July 31, 2020.

Second Quarter Fiscal 2021 Noteworthy Items

• 
  Net sales in

Smiths Detection announced that Incheon International Airport Corporation (IIAC) has successfully trialled its Computed Tomography (CT) technology based carry-on baggage scanner, HI-SCAN 6040 CTiX

Singapore Changi Airport will deploy 20 units of ultra-high speed Smiths Detection HI-SCAN 10080 XCT automatic explosives detection systems (EDS) for the redevelopment of Terminal 2 Baggage

Raven Industries, Inc. (the Company; NASDAQ:RAVN) announced today that its Engineered Films division has introduced a new BioFlex™ I-Series plastic film product line to assist with the urgent

Smiths Detection today announced its collaboration with Philippines' Office for Transportation Security (OTS) and Manila International Airport Authority (MIAA) to boost passenger throughput and

Raven Industries, Inc. (the Company; NASDAQ:RAVN) announced today two advancements for its market-leading VSN® Visual Guidance System, building upon the Company’s bold investment in Raven Autonomy

Raven Industries, Inc. (the Company; NASDAQ:RAVN) announced today that its enhanced focus on cash flow during the pandemic is leading to improved liquidity.

In the second quarter, the Company

Raven Industries, Inc. (the Company; NASDAQ:RAVN) announced today that it will host a virtual Investor Day event on Thursday, August 27, 2020. The event will feature demonstrations of the Company’s

Raven Industries, Inc. (the Company; NASDAQ:RAVN) announced today that its Engineered Films Division has received a $4.8 million contract award from the Federal Emergency Management Agency (FEMA)

Raven Industries, Inc. (the Company; NASDAQ:RAVN), announced today that its board of directors has approved a regular quarterly cash dividend of 13 cents per share. The dividend is payable July 31

Raven Industries, Inc. (the Company; NASDAQ:RAVN) today reported financial results for the first quarter that ended April 30, 2020.

First Quarter Fiscal 2021 Noteworthy Items

• 
  Economic decline

Raven Industries, Inc. (the Company; NASDAQ:RAVN) announced today the release of Slingshot® Fleet Tracking. Backed by Razor Tracking, the platform allows users to wirelessly track the location and

Raven Industries, Inc. (the Company; NASDAQ:RAVN) announced today that it will conduct a live webcast of its Annual Meeting of Shareholders on Wednesday, May 20, 2020 at 9:00 a.m. Central Time. The

As part of its ongoing commitment to autonomous agriculture solutions, Raven Industries, Inc. (the Company; NASDAQ:RAVN) announced today that it has entered into agreements to acquire the remaining

Raven Industries, Inc. (the Company; NASDAQ:RAVN) today reported financial results for the fourth quarter that ended January 31, 2020.

Fourth Quarter Fiscal 2020 Noteworthy Items:

• 
  Applied

Raven Industries, Inc. (the Company; NASDAQ:RAVN) announced today that it will issue its fiscal fourth-quarter 2020 results after market close on Monday, March 23, 2020.

Following the release

Raven Industries, Inc. (NASDAQ:RAVN), announced today that its board of directors has approved a regular quarterly cash dividend of 13 cents per share. The dividend is payable April 27, 2020, to

Raven Industries, Inc. (The Company; NASDAQ:RAVN) announced today that Raven Aerostar has added a new solution to its advanced radar suite. The HiPointer 100 is a lightweight, highly-mobile

Raven Industries, Inc. (the Company; NASDAQ:RAVN), has partnered with Razor Tracking, a SaaS and mobile application based fleet tracking and management system, to provide ag retailers and

The U.S. Food and Drug Administration (FDA) has approved Clariscan™, a macrocyclic, ionic, gadolinium-based, MRI contrast agent, expanding the GE Healthcare portfolio for U.S. patients and